A visionary leader in the field of biomedical circuits and systems, Christofer Toumazou’s groundbreaking contributions to the design, implementation, and clinical application of integrated microchip technology solutions for intelligent diagnostics and therapy have transformed medical practice. In 2001, Dr. Toumazou developed semiconductor genomic sequencing. Other achievements include cochlear implants for children born deaf, an artificial pancreas for type 1 diabetics, wireless heart monitors for personalized ambulatory care, semiconductor-based DNA sequencing, and an intelligent neural stimulator as a drug alternative for obesity. In 1994, Dr. Toumazou became the youngest professor to be appointed at Imperial College London.
An IEEE Fellow, Dr. Toumazou is founder and Chief Scientist of the Institute of Biomedical Engineering, Imperial College London and founder of three successful healthcare companies (Toumaz, DNA Electronics, and GENEU).